heartflow.comHealthcare / Healthcare providers & servicesFounded: 2007Funding to Date: $1.06B
HeartFlow is revolutionizing precision heart care, combining human ingenuity with advanced AI technology. They began their journey to improve coronary artery disease diagnosis with FFRCT and have now expanded their product portfolio to include anatomic stenosis and plaque information. This company was founded by Charles Taylor, Christopher Zarins, and John Stevens in 2007 and is headquartered in Redwood City, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
06/13/2019 | Series E | $305MM | $xx.xx | $1.65B | Baillie Gifford, Wellington Management | |
Price per Share
$xx.xx
Shares Outstanding
13,422,649
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Baillie Gifford, Wellington Management
|
||||||
05/10/2016 | Series D | $99.93MM | $xx.xx | $771.66MM | Bluecross Blueshield Venture Partners, Panorama Point Partners, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
7,151,873
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluecross Blueshield Venture Partners, Panorama Point Partners, Undisclosed Investors
|
||||||
02/26/2014 | Series C | $104.7MM | $xx.xx | $373.44MM | Capricorn Investment Group, Healthcor Management, Sandbox Industries, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
11,343,434
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Capricorn Investment Group, Healthcor Management, Sandbox Industries, Undisclosed Investors
|
||||||
02/04/2011 | Series B-2 | $10.11MM | $xx.xx | $90.13MM | Ge Ventures, Healthcor Partners Management, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,848,263
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ge Ventures, Healthcor Partners Management, Undisclosed Investors
|
||||||
02/04/2011 | Series B-1 | $6.94MM | $xx.xx | $90.13MM | Ge Ventures, Healthcor Partners Management, Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
1,954,846
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ge Ventures, Healthcor Partners Management, Undisclosed Investors
|
||||||
04/16/2010 | Series A | $2.04MM | $xx.xx | $8.17MM | Bluecross Blueshield Venture Partners, Capricorn Healthcare, Emergent Medical Partners, Special Opportunities, U.S. Venture Partners | |
Price per Share
$xx.xx
Shares Outstanding
4,082,965
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Bluecross Blueshield Venture Partners, Capricorn Healthcare, Emergent Medical Partners, Special Opportunities, U.S. Venture Partners
|